New drug combo IDB-011 tested for safety against rift valley fever
Prevention
Ongoing
This early-stage trial is testing the safety of a new drug combination called IDB-011 in 40 healthy adults. The goal is to see if it is safe and how the body processes it, as a first step toward possibly preventing Rift Valley Fever, a viral disease spread by mosquitoes. Particip…
Phase: PHASE1 • Sponsor: IDBiologics, Inc. • Aim: Prevention
Last updated Jun 24, 2026 11:05 UTC